CE vs XFOR · rev $10.28B vs rev $6.5M
Celanese Corporation (CE) versus X4 Pharmaceuticals Inc (XFOR) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
X4 Pharmaceuticals Inc (XFOR) is a biotechnology company listed on NASDAQ.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported XFOR revenue for 2025-12-31 was $6.5M. Net income was -$79.2M. Revenue was up 154.2% from 2024-12-31 to 2025-12-31. XFOR currently screens at market cap $382.0M.
CE currently screens at market cap $5.92B. XFOR currently screens at market cap $382.0M.
Not investment advice. Open the CE and XFOR stock pages for the full models.
Not investment advice.